N-hydroxy-4-(4-(4-(4-(2-methoxyethyl)piperazine-1-carbonyl)piperidin-1-yl)phenylsulfonyl)tetrahydro-2H-pyran-4-carboxamide

InChIKey	`BTDOGCFKKXBYKB-UHFFFAOYSA-N`
Compound Name	N-hydroxy-4-(4-(4-(4-(2-methoxyethyl)piperazine-1-carbonyl)piperidin-1-yl)phenylsulfonyl)tetrahydro-2H-pyran-4-carboxamide
Canonical SMILES	`COCCN1CCN(C(=O)C2CCN(c3ccc(S(=O)(=O)C4(C(=O)NO)CCOCC4)cc3)CC2)CC1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	7.35
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P08253	MMP2	Homo sapiens	Human	PF00040 PF00045 PF00413	7.3	pIC50	TTD_MultiTarget
P45452	MMP13	Homo sapiens	Human	PF00045 PF00413 PF01471	7.3	IC50	ChEMBL;BindingDB
P18843	nadE	Escherichia coli (strain K12)	Pathogen	PF02540	7.3	pIC50	TTD_MultiTarget